NSK-01105, a Novel Sorafenib Derivative, Inhibits Human Prostate Tumor Growth via Suppression of VEGFR2/EGFR-Mediated Angiogenesis

Pengfei Yu(Shenyang Pharmaceutical University), Jingwei Tian(Yantai University)
PLoS ONE
December 31, 2014
Cited by 13


Related Papers